Collaboration for rare disease drug discovery research
نویسندگان
چکیده
منابع مشابه
Collaboration for rare disease drug discovery research
Rare disease research has reached a tipping point, with the confluence of scientific and technologic developments that if appropriately harnessed, could lead to key breakthroughs and treatments for this set of devastating disorders. Industry-wide trends have revealed that the traditional drug discovery research and development (R&D) model is no longer viable, and drug companies are evolving the...
متن کاملDrug Discovery Research for Hydrocephalus
In 2013, clinical and basic science research has rolled the dice further to extend our understanding to hydrocephalus. A group of research team at Boston Children’s Hospital and Harvard Medical School, led by neurosurgeon, Joseph Madsen, has published the laboratory investigation results on vascular endothelial growth factor, VEGF, and showed its potential effect on the development of experimen...
متن کاملOrphan/rare drug discovery through drug repositioning
There are many, often life-threatening, rare/orphan diseases for which there are few or no therapeutic options. They individually affect few people, but collectively impose very high social and economic burdens. New approaches are bringing big pharma resources to solving the problem through drug repositioning of approved drugs. Advances are being spurred by public and private partnerships, gove...
متن کاملCollaboration in Health Research
سخن سردبیر Editorial مجله دانشگاه علوم پزشکی رفسنجان دوره 20، خرداد 1400، 258-257 همکاری در پژوهشهای علوم سلامت Collaboration in Health Research محسن رضائیان[1] M. Rezaeian همکاری (Collaboration) در پژوهشهای علوم سلامت، جزء ضروری برای به موفقیت رسیدن چنین پژوهشهایی است. قبلاً در یکی از سخنان سردبیری مجله دانشگاه به مقالاتی اشاره کردیم که ممکن است تعداد نویسندگان آنه...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: F1000Research
سال: 2014
ISSN: 2046-1402
DOI: 10.12688/f1000research.5564.1